Skip to main content

Table 2 Outcomes in NSAID cohort and propensity-matched control cohort

From: NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

 

NSAID

Control

COVID-19 severity

  

Moderate

18,023 (91.3%)

16,972 (86%)

Severe

776 (3.9%)

1047 (5.3%)

Dead

947 (4.8%)

1727 (8.8%)

Invasive ventilation

1150 (5.8%)

1867 (9.5%)

AKI

1729 (8.8%)

2437 (12.3%)

ECMO

54 (0.27%)

109 (0.55%)

  1. Number of patients and percent of cohort for each outcome are shown
  2. AKI acute kidney injury; ECMO extracorporeal membrane oxygenation
Back to article page

Virology Journal

ISSN: 1743-422X